4//SEC Filing
DeMuth Peter 4
Accession 0001601485-24-000109
CIK 0001601485other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:51 PM ET
Size
6.9 KB
Accession
0001601485-24-000109
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-12-16$4.41/sh+381$1,680→ 381 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-16−381→ 0 totalExercise: $4.41Exp: 2024-12-18→ Common Stock (381 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 18, 2015, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001979163
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:51 PM ET
- Size
- 6.9 KB